BCIQ Profiles

Company Profile Report
0414 DDR at AACR
BioCentury & Getty Images

Product Development

Next-generation DNA damage response programs at AACR

Apr 15, 2021 | 1:10 AM GMT

Clinical readouts for WEE1 inhibitors, next-generation compounds against PARP and a pair of agents targeting CDC7 were among the DNA damage

Read the full 437 word article

How to gain access

Continue reading with a
two-week free trial.